Adam P. Lightfoot

1.2k total citations
31 papers, 884 citations indexed

About

Adam P. Lightfoot is a scholar working on Molecular Biology, Rehabilitation and Physiology. According to data from OpenAlex, Adam P. Lightfoot has authored 31 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Rehabilitation and 7 papers in Physiology. Recurrent topics in Adam P. Lightfoot's work include Muscle Physiology and Disorders (16 papers), Exercise and Physiological Responses (8 papers) and Mitochondrial Function and Pathology (6 papers). Adam P. Lightfoot is often cited by papers focused on Muscle Physiology and Disorders (16 papers), Exercise and Physiological Responses (8 papers) and Mitochondrial Function and Pathology (6 papers). Adam P. Lightfoot collaborates with scholars based in United Kingdom, Lithuania and France. Adam P. Lightfoot's co-authors include Anastasia Thoma, Anne McArdle, Robert Cooper, Richard Griffiths, Malcolm J. Jackson, Gareth Nye, Giorgos K. Sakellariou, Fiona L. Wilkinson, Tim Pearson and Robert G. Cooper and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Adam P. Lightfoot

30 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam P. Lightfoot United Kingdom 15 461 322 160 123 116 31 884
Johanna Ábrigo Chile 21 593 1.3× 522 1.6× 151 0.9× 129 1.0× 221 1.9× 29 1.1k
Marissa K. Caldow Australia 18 487 1.1× 470 1.5× 79 0.5× 208 1.7× 320 2.8× 37 978
Randall F. D’Souza New Zealand 21 642 1.4× 484 1.5× 86 0.5× 150 1.2× 336 2.9× 48 1.2k
Jong Han Lee South Korea 15 413 0.9× 553 1.7× 260 1.6× 124 1.0× 120 1.0× 29 1.3k
Claire Laurens France 17 266 0.6× 484 1.5× 117 0.7× 69 0.6× 125 1.1× 25 793
Yuko Tanimura Japan 20 470 1.0× 419 1.3× 111 0.7× 241 2.0× 139 1.2× 33 1.2k
Nina Zeng New Zealand 16 409 0.9× 320 1.0× 55 0.3× 74 0.6× 212 1.8× 39 815
Takako Maruyama Japan 12 508 1.1× 269 0.8× 156 1.0× 96 0.8× 113 1.0× 27 1.2k
Andrew J. Murton United States 21 491 1.1× 596 1.9× 148 0.9× 254 2.1× 498 4.3× 60 1.2k
Giosuè Annibalini Italy 18 545 1.2× 345 1.1× 71 0.4× 156 1.3× 168 1.4× 41 1.1k

Countries citing papers authored by Adam P. Lightfoot

Since Specialization
Citations

This map shows the geographic impact of Adam P. Lightfoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam P. Lightfoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam P. Lightfoot more than expected).

Fields of papers citing papers by Adam P. Lightfoot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam P. Lightfoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam P. Lightfoot. The network helps show where Adam P. Lightfoot may publish in the future.

Co-authorship network of co-authors of Adam P. Lightfoot

This figure shows the co-authorship network connecting the top 25 collaborators of Adam P. Lightfoot. A scholar is included among the top collaborators of Adam P. Lightfoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam P. Lightfoot. Adam P. Lightfoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heaton, Robert A., A. J. BATEMAN, Nasser Al‐Shanti, et al.. (2025). The effect of simvastatin induced neurotoxicity on mitochondrial function in human neuronal cells. Toxicology Mechanisms and Methods. 35(6). 592–603. 1 indexed citations
2.
Thoma, Anastasia, et al.. (2024). A combination of major histocompatibility complex (MHC) I overexpression and type I interferon induce mitochondrial dysfunction in human skeletal myoblasts. Journal of Cellular Physiology. 240(1). e31458–e31458. 2 indexed citations
3.
Bell, G.M., Anastasia Thoma, Iain P. Hargreaves, & Adam P. Lightfoot. (2024). The Role of Mitochondria in Statin-Induced Myopathy. Drug Safety. 47(7). 643–653. 12 indexed citations
4.
Thoma, Anastasia, et al.. (2022). Major histocompatibility complex I‐induced endoplasmic reticulum stress mediates the secretion of pro‐inflammatory muscle‐derived cytokines. Journal of Cellular and Molecular Medicine. 26(24). 6032–6041. 10 indexed citations
5.
Robinson, Susan W., et al.. (2022). Cdk1-mediated threonine phosphorylation of Sam68 modulates its RNA binding, alternative splicing activity and cellular functions. Nucleic Acids Research. 50(22). 13045–13062. 8 indexed citations
6.
7.
Houacine, Chahinez, Fiona L. Wilkinson, Adam P. Lightfoot, et al.. (2021). Nanostructured Lipid Carriers Deliver Resveratrol, Restoring Attenuated Dilation in Small Coronary Arteries, via the AMPK Pathway. Biomedicines. 9(12). 1852–1852. 9 indexed citations
8.
Thoma, Anastasia, et al.. (2020). MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies. BMC Rheumatology. 4(1). 25–25. 18 indexed citations
9.
Thoma, Anastasia, Max Lyon, Nasser Al‐Shanti, et al.. (2020). Eukarion-134 Attenuates Endoplasmic Reticulum Stress-Induced Mitochondrial Dysfunction in Human Skeletal Muscle Cells. Antioxidants. 9(8). 710–710. 13 indexed citations
10.
Thoma, Anastasia, et al.. (2020). Targeting reactive oxygen species (ROS) to combat the age-related loss of muscle mass and function. Biogerontology. 21(4). 475–484. 33 indexed citations
11.
Faroni, Alessandro, Adam J. Reid, Adam P. Lightfoot, et al.. (2019). <p>Simplified in vitro engineering of neuromuscular junctions between rat embryonic motoneurons and immortalized human skeletal muscle cells</p>. SHILAP Revista de lepidopterología. Volume 12. 1–9. 9 indexed citations
12.
Thoma, Anastasia & Adam P. Lightfoot. (2018). NF-kB and Inflammatory Cytokine Signalling: Role in Skeletal Muscle Atrophy. Advances in experimental medicine and biology. 1088. 267–279. 228 indexed citations
13.
Sakellariou, Giorgos K., Tim Pearson, Adam P. Lightfoot, et al.. (2016). Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy. Scientific Reports. 6(1). 33944–33944. 104 indexed citations
14.
Lightfoot, Adam P. & Robert Cooper. (2016). The role of myokines in muscle health and disease. Current Opinion in Rheumatology. 28(6). 661–666. 65 indexed citations
15.
16.
Lightfoot, Adam P., Kanneboyina Nagaraju, Anne McArdle, & Robert Cooper. (2015). Understanding the origin of non-immune cell-mediated weakness in the idiopathic inflammatory myopathies – potential role of ER stress pathways. Current Opinion in Rheumatology. 27(6). 580–585. 29 indexed citations
17.
Lightfoot, Adam P., Anne McArdle, Malcolm J. Jackson, & Robert G. Cooper. (2015). In the idiopathic inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to muscle weakness?. Annals of the Rheumatic Diseases. 74(7). 1340–1346. 41 indexed citations
18.
Lightfoot, Adam P., Giorgos K. Sakellariou, Gareth Nye, et al.. (2015). SS-31 attenuates TNF-α induced cytokine release from C2C12 myotubes. Redox Biology. 6. 253–259. 32 indexed citations
19.
Lightfoot, Adam P., Rachel McCormick, Gareth Nye, & Anne McArdle. (2014). Mechanisms of skeletal muscle ageing; avenues for therapeutic intervention. Current Opinion in Pharmacology. 16. 116–121. 22 indexed citations
20.
Lightfoot, Adam P., Anne McArdle, & Richard Griffiths. (2009). Muscle in defense. Critical Care Medicine. 37(10 Suppl). S384–S390. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna Ábrigo Breakdown of academic impact, for papers by Marissa K. Caldow Breakdown of academic impact, for papers by Randall F. D’Souza Breakdown of academic impact, for papers by Jong Han Lee Breakdown of academic impact, for papers by Claire Laurens Breakdown of academic impact, for papers by Yuko Tanimura Breakdown of academic impact, for papers by Nina Zeng Breakdown of academic impact, for papers by Takako Maruyama Breakdown of academic impact, for papers by Andrew J. Murton Breakdown of academic impact, for papers by Giosuè Annibalini
Rankless by CCL
2026